Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1992 1
1993 1
1994 1
1995 2
1996 4
1997 3
1999 1
2000 1
2010 1
2012 4
2013 2
2014 1
2015 4
2016 4
2017 5
2018 10
2019 7
2020 10
2021 5
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Integrins in the Spotlight of Cancer.
Bianconi D, Unseld M, Prager GW. Bianconi D, et al. Among authors: unseld m. Int J Mol Sci. 2016 Dec 6;17(12):2037. doi: 10.3390/ijms17122037. Int J Mol Sci. 2016. PMID: 27929432 Free PMC article. Review.
Angiogenesis in cancer: Anti-VEGF escape mechanisms.
Prager GW, Poettler M, Unseld M, Zielinski CC. Prager GW, et al. Among authors: unseld m. Transl Lung Cancer Res. 2012 Mar;1(1):14-25. doi: 10.3978/j.issn.2218-6751.2011.11.02. Transl Lung Cancer Res. 2012. PMID: 25806151 Free PMC article. Review.
The HDL particle composition determines its antitumor activity in pancreatic cancer.
Oberle R, Kührer K, Österreicher T, Weber F, Steinbauer S, Udonta F, Wroblewski M, Ben-Batalla I, Hassl I, Körbelin J, Unseld M, Jauhiainen M, Plochberger B, Röhrl C, Hengstschläger M, Loges S, Stangl H. Oberle R, et al. Among authors: unseld m. Life Sci Alliance. 2022 May 16;5(9):e202101317. doi: 10.26508/lsa.202101317. Print 2022 Sep. Life Sci Alliance. 2022. PMID: 35577388 Free PMC article.
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.
Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M, Fürnkranz K, Famler B, Schmeidl M, Minichsdorfer C, Zielinski C, Heller G, Prager GW. Bianconi D, et al. Among authors: unseld m. Transl Oncol. 2019 Jan;12(1):15-23. doi: 10.1016/j.tranon.2018.08.019. Epub 2018 Sep 20. Transl Oncol. 2019. PMID: 30245304 Free PMC article.
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Unseld M, Belic J, Pierer K, Zhou Q, Moser T, Bauer R, Piringer G, Gerger A, Siebenhüner A, Speicher M, Heitzer E, Prager GW. Unseld M, et al. Int J Cancer. 2021 Mar 15;148(6):1452-1461. doi: 10.1002/ijc.33303. Epub 2020 Oct 16. Int J Cancer. 2021. PMID: 32949150 Free PMC article. Clinical Trial.
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI.
Taghizadeh H, Unseld M, Spalt M, Mader RM, Müllauer L, Fuereder T, Raderer M, Sibilia M, Hoda MA, Aust S, Polterauer S, Lamm W, Bartsch R, Preusser M, A KW, Prager GW. Taghizadeh H, et al. Among authors: unseld m. J Pers Med. 2020 Oct 23;10(4):188. doi: 10.3390/jpm10040188. J Pers Med. 2020. PMID: 33114048 Free PMC article.
74 results